41 results on '"Le Rhun, Émilie'
Search Results
2. Translating the theranostic concept to neuro-oncology: disrupting barriers
3. “Symptomatic” melanoma brain metastases: A call for clear definitions and adoption of standardized tools
4. Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management
5. Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial
6. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
7. Pharmacotherapy for leptomeningeal disease in breast cancer
8. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
9. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
10. Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101
11. Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
12. Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival
13. The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth
14. Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
15. Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma
16. Ethanol Exposure During the Intravenous Administration of Chemotherapeutic Drugs: An Analysis of Clinical Practice and a Literature Review
17. Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
18. How we treat glioblastoma
19. How we treat patients with leptomeningeal metastases
20. Corrigendum to “Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial” [Eur J Cancer 198 (2024) 113475]
21. Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
22. Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
23. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis
24. The Evolving Landscape of Brain Metastasis
25. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer
26. 3088: Association of brain metastases with classification, treatment, and outcomes of extracranial OMD
27. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification
28. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
29. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
30. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
31. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
32. Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
33. Ethanol Exposure During the Intravenous Administration of Chemotherapeutic Drugs: An Analysis of Clinical Practice and a Literature Review.
34. Response to "Intrathecal trastuzumab: What else do we need to consider?" by Gao et al.
35. Bringing mass spectrometry from pathologist bench to patient bedside
36. Oligoastrocytome associé à une acidurie L-2-hydroxyglutarique
37. Intérêt d’un traitement intrathécal de seconde ligne par thiotepa dans les atteintes méningées de cancer du sein
38. Réponse prolongée après traitement de méningite tumorale de cancer du sein : à propos de deux cas
39. P1-048 Natural history of primary progressive aphasia
40. Response to "Intrathecal trastuzumab: What else do we need to consider?" by Gao et al.
41. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.